NGVTIngevity Corporation
Is it safe?
Solid, nothing alarming: a safe balance sheet, but heavy debt (CCC) and big price swings.
Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.
Mixed fundamental signals Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.
Insiders were net sellers (-$1.7M, 90 days to Oct 8, 2026), selling is often routine.
Highly leveraged, watch solvency. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -76% · now 10% below its 52-week high.
Unless marked, from SEC EDGAR, as of Dec 31, 2025.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can NGVT take a bad year?
The deepest fall in NGVT's price history on file is −76%; it is 10% below its high today.
Net debt · as at Q2 2026 · debt less the cash on hand
- Altman Z-score
- 2.92
Altman Z-score · grey zone, between 1.8 and 3
- Debt / equity
- 25.6×
Debt / equity
- Annualised volatility
- 48%
Annualised volatility · roughly twice as jumpy as the market
Details›
- Total debtQ2 2026
- $1.20B
- Cash and short-term investments
- $97M
- Net debt
- $1.10B
- Debt / equity
- 25.6×
- Annualised volatilitytwo years of daily moves
- 48%
- Worst drawdown on file
- −76%
- Below its 52-week high
- 10%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Specialty Chemicals
Ranks #5 of 33 by RyuScore